Raymond James & Associates 23and Me Holding Co. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in 23and Me Holding Co. stock. As of the latest transaction made, Raymond James & Associates holds 75,614 shares of ME stock, worth $288,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,614

Previous 75,614 -0.0%

Holding current value

$288,845

Previous $29,000 10.34%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$0.36 - $0.61 $3,600 - $6,100	-10,000 Reduced 11.68%	75,614 $29,000
Q1 2024 Apr 22, 2024	BUY	$0.4 - $0.91 $7,856 - $17,873	19,641 Added 29.77%	85,614 $45,000
Q4 2023 Jan 16, 2024	BUY	$0.71 - $0.97 $21,158 - $28,906	29,800 Added 82.38%	65,973 $60,000
Q3 2023 Oct 24, 2023	BUY	$0.96 - $2.01 $18,463 - $38,658	19,233 Added 113.54%	36,173 $35,000
Q2 2023 Jul 25, 2023	BUY	$1.59 - $2.29 $8,104 - $11,672	5,097 Added 43.04%	16,940 $29,000
Q1 2023 Apr 14, 2023	BUY	$2.05 - $2.87 $776 - $1,087	379 Added 3.31%	11,843 $27,000
Q4 2022 Feb 08, 2023	SELL	$2.06 - $3.47 $18,583 - $31,302	-9,021 Reduced 44.04%	11,464 $24,000
Q3 2022 Oct 25, 2022	BUY	$2.6 - $5.12 $16,341 - $32,179	6,285 Added 44.26%	20,485 $59,000
Q2 2022 Aug 12, 2022	SELL	$2.19 - $3.98 $57,115 - $103,798	-26,080 Reduced 64.75%	14,200 $35,000
Q1 2022 May 11, 2022	BUY	$3.28 - $7.12 $12,637 - $27,433	3,853 Added 10.58%	40,280 $154,000
Q4 2021 Feb 08, 2022	BUY	$6.55 - $13.25 $134,746 - $272,579	20,572 Added 129.75%	36,427 $243,000
Q3 2021 Nov 02, 2021	SELL	$7.29 - $11.0 $45,125 - $68,090	-6,190 Reduced 28.08%	15,855 $144,000
Q2 2021 Aug 11, 2021	BUY	$9.87 - $13.32 $217,584 - $293,639	22,045 New	22,045 $258,000

Others Institutions Holding ME

# of Institutions

116

Shares Held

82.6M

Call Options Held

404K

Put Options Held

292K

View Full List

About 23andMe Holding Co.

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $992M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

More about ME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates 23and Me Holding Co. Transaction History